Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Tumor-suppressive microRNAs in Lung cancer: diagnostic and therapeutic opportunities.

Sempere LF, Liu X, Dmitrovsky E.

ScientificWorldJournal. 2009 Jul 13;9:626-8. doi: 10.1100/tsw.2009.88.

2.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
3.

Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.

Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N.

J Hum Genet. 2012 Jan;57(1):38-45. doi: 10.1038/jhg.2011.126. Epub 2011 Nov 17.

PMID:
22089643
4.

Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.

Guan P, Yin Z, Li X, Wu W, Zhou B.

J Exp Clin Cancer Res. 2012 Jun 6;31:54. doi: 10.1186/1756-9966-31-54.

5.

Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.

Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J, Chen L.

J Thorac Cardiovasc Surg. 2015 May;149(5):1404-14.e4. doi: 10.1016/j.jtcvs.2015.02.012. Epub 2015 Feb 12.

6.

Uncovering growth-suppressive MicroRNAs in lung cancer.

Liu X, Sempere LF, Galimberti F, Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li H, DiRenzo J, Korc M, Cole CN, Bak M, Kauppinen S, Dmitrovsky E.

Clin Cancer Res. 2009 Feb 15;15(4):1177-83. doi: 10.1158/1078-0432.CCR-08-1355.

7.

MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.

Kang SM, Lee HJ, Cho JY.

Cancer Lett. 2013 Jul 28;335(2):487-94. doi: 10.1016/j.canlet.2013.03.006. Epub 2013 Mar 16.

PMID:
23507558
8.

Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.

Pak MG, Lee CH, Lee WJ, Shin DH, Roh MS.

Diagn Pathol. 2015 Jul 12;10:99. doi: 10.1186/s13000-015-0339-4.

9.

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E.

J Clin Invest. 2010 Apr;120(4):1298-309. doi: 10.1172/JCI39566. Epub 2010 Mar 8.

10.

Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.

Ling B, Wang GX, Long G, Qiu JH, Hu ZL.

J Cancer Res Clin Oncol. 2012 Aug;138(8):1355-61. doi: 10.1007/s00432-012-1194-2. Epub 2012 Apr 7.

PMID:
22484852
11.

Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.

He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z, Duan C.

Mol Cancer. 2015 Apr 1;14:73. doi: 10.1186/s12943-015-0342-0.

12.

MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer.

Li Q, Li X, Guo Z, Xu F, Xia J, Liu Z, Ren T.

PLoS One. 2012;7(11):e48278. doi: 10.1371/journal.pone.0048278. Epub 2012 Nov 2.

13.

An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.

Begum S, Hayashi M, Ogawa T, Jabboure FJ, Brait M, Izumchenko E, Tabak S, Ahrendt SA, Westra WH, Koch W, Sidransky D, Hoque MO.

Sci Rep. 2015 Aug 28;5:13236. doi: 10.1038/srep13236.

14.

Breast cancer and microRNAs: therapeutic impact.

Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E.

Breast. 2011 Oct;20 Suppl 3:S63-70. doi: 10.1016/S0960-9776(11)70297-1. Review.

PMID:
22015296
15.

MicroRNA expression and clinical outcome of small cell lung cancer.

Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G.

PLoS One. 2011;6(6):e21300. doi: 10.1371/journal.pone.0021300. Epub 2011 Jun 22.

16.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

17.

MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.

Li J, Yu T, Cao J, Liu L, Liu Y, Kong HW, Zhu MX, Lin HC, Chu DD, Yao M, Yan MX.

Cell Physiol Biochem. 2015;37(5):1847-56. doi: 10.1159/000438546. Epub 2015 Nov 17.

18.

MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.

Xu W, Hang M, Yuan CY, Wu FL, Chen SB, Xue K.

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3864-70. eCollection 2015.

19.

MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1.

You J, Zhang Y, Liu B, Li Y, Fang N, Zu L, Li X, Zhou Q.

Indian J Cancer. 2014 Mar;51 Suppl 3:e77-81. doi: 10.4103/0019-509X.154055.

20.

Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.

Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, Kettunen E, Anttila S, Knuutila S.

Genes Chromosomes Cancer. 2011 Aug;50(8):585-97. doi: 10.1002/gcc.20880. Epub 2011 May 11.

PMID:
21563230

Supplemental Content

Support Center